Concomitant RAS and BRAF V600E Mutations in Unresectable Metastatic CRC: A Case of Long-term Survival
{{output}}
Detection of rat sarcoma virus (RAS) and B rapidly accelerated fibrosarcoma (BRAF) mutations is critical for selecting an appropriate treatment for metastatic colorectal cancer (mCRC). Although RAS and BRAF V600E mutations are traditionally mutually exclusive,... ...
